X — Xenotropic Murine Leukemia Virus–Related Virus (XMRV)
XMRV is a recombinant gammaretrovirus initially reported in human prostate cancer and chronic fatigue syndrome. Subsequent investigations revealed that it arose from recombination of murine leukemia viruses during passage of human tumor cells in mice, representing laboratory contamination rather than a genuine human pathogen.
Although not clinically relevant as a human virus, XMRV profoundly impacted virology research methodology. It highlighted the risks of contamination in PCR-based detection assays, the importance of rigorous phylogenetic analysis, and the need for reproducibility across laboratories.
The episode reinforced standards for retroviral discovery, including integration site analysis, demonstration of replication competence in human cells, and exclusion of mouse DNA contamination.
Thus, XMRV remains significant as a case study in scientific rigor, viral discovery, and the interface between molecular detection technologies and clinical interpretation.
XMRV is a recombinant gammaretrovirus initially reported in human prostate cancer and chronic fatigue syndrome. Subsequent investigations revealed that it arose from recombination of murine leukemia viruses during passage of human tumor cells in mice, representing laboratory contamination rather than a genuine human pathogen.
Although not clinically relevant as a human virus, XMRV profoundly impacted virology research methodology. It highlighted the risks of contamination in PCR-based detection assays, the importance of rigorous phylogenetic analysis, and the need for reproducibility across laboratories.
The episode reinforced standards for retroviral discovery, including integration site analysis, demonstration of replication competence in human cells, and exclusion of mouse DNA contamination.
Thus, XMRV remains significant as a case study in scientific rigor, viral discovery, and the interface between molecular detection technologies and clinical interpretation.